United Therapeutics (UTHR) Assets Average (2010 - 2026)
United Therapeutics (UTHR) posted Assets Average of $7.3 billion for Q1 2026, down 4.18% sequentially from $7.6 billion in Q4 2025, and down 3.4% YoY from $7.6 billion in Q1 2025.
United Therapeutics (UTHR) Assets Average (2010 - 2026) Analysis & Trends
United Therapeutics has reported Assets Average for 17 years, with the latest figure at $7.3 billion in Q1 2026.
- Quarterly Assets Average fell 3.4% year-over-year to $7.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.3 billion (down 3.4% YoY) and the FY2025 annual result came in at $7.6 billion, up 4.91% from the prior year.
- Assets Average declined to $7.3 billion in Q1 2026 per UTHR's latest filing, from $7.6 billion in the prior quarter.
- Over five years, Assets Average peaked at $7.8 billion in Q2 2025 and troughed at $3.4 billion in Q3 2024.
- A 5-year average of $6.3 billion and a median of $6.6 billion in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2024 and 2025: Assets Average sank 50.92% in 2024, then jumped 126.87% in 2025.
- Over 5 years, Assets Average stood at $5.9 billion in 2022, then grew by 19.99% to $7.1 billion in 2023, then slumped by 48.09% to $3.7 billion in 2024, then jumped by 106.76% to $7.6 billion in 2025, then retreated by 4.18% to $7.3 billion in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $7.3 billion, $7.6 billion, and $7.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 5.97 Bn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 4.33 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.97 Bn |
| Mar 31, 2026 | 7.30 Bn |
| Dec 31, 2025 | 7.62 Bn |
| Sep 30, 2025 | 7.63 Bn |
| Jun 30, 2025 | 7.83 Bn |
| Mar 31, 2025 | 7.55 Bn |
| Dec 31, 2024 | 3.68 Bn |
| Sep 30, 2024 | 3.36 Bn |
| Jun 30, 2024 | 6.61 Bn |
| Mar 31, 2024 | 6.83 Bn |
| Dec 31, 2023 | 7.10 Bn |
| Sep 30, 2023 | 6.85 Bn |
| Jun 30, 2023 | 6.51 Bn |
| Mar 31, 2023 | 6.20 Bn |
| Dec 31, 2022 | 5.91 Bn |
| Sep 30, 2022 | 5.66 Bn |
| Jun 30, 2022 | 5.45 Bn |
| Mar 31, 2022 | 5.26 Bn |
| Dec 31, 2021 | 5.11 Bn |
| Sep 30, 2021 | 4.95 Bn |